Author

Chuck W. Locuson

Observed names: C. W. LOCUSON, Chuck Locuson, Locuson, Chuck

Institution: Agios Pharmaceuticals (United States)

Observed institutions: Pfizer (United States), Vanderbilt University, Agios Pharmaceuticals (United States), University of Minnesota, Duluth

ORCID: 0009-0001-6304-8939

Observed ORCID: 0009-0001-6304-8939

OpenAlex ID: A5081772103

Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics

2013 · Marilyn N. Martinez, Leposava Antonovic, et al. · Drug Metabolism Reviews · 65

Discovery of ( S )-2-Cyclopentyl- N -((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1 H -pyrrido[3,4- b ]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)

2014 · Lindsey C. Morris, Kellie D. Nance, et al. · Journal of Medicinal Chemistry · 49

Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs

2009 · M. T. BARATTA, M. J. ZAYA, et al. · Journal of Veterinary Pharmacology and Therapeutics · 26

Amiodarone Analog-Dependent Effects on CYP2C9-Mediated Metabolism and Kinetic Profiles

2006 · Vikas Kumar, Chuck W. Locuson, et al. · Drug Metabolism and Disposition · 19

Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery

2023 · Unnati Kapadnis, Chuck Locuson, et al. · Bioanalysis · 3

Hepatocyte-Based Models for CYP450 Fraction Metabolized Determination: Recommendations from the Quantitative Fraction Metabolized IQ Consortium Working Group

2026 · Angela C. Doran, Vincent C. Peterkin, et al. · Drug Metabolism and Disposition

Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice

2026 · Chuck Locuson, Sebastien Ronseaux, et al. · Biopharmaceutics & Drug Disposition

Works count: 8

Citation count: 162

H-index: 4

I10-index: 4